AU498384B2 - Anti-timor composition - Google Patents

Anti-timor composition

Info

Publication number
AU498384B2
AU498384B2 AU78573/75A AU7857375A AU498384B2 AU 498384 B2 AU498384 B2 AU 498384B2 AU 78573/75 A AU78573/75 A AU 78573/75A AU 7857375 A AU7857375 A AU 7857375A AU 498384 B2 AU498384 B2 AU 498384B2
Authority
AU
Australia
Prior art keywords
timor
composition
timor composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU78573/75A
Other versions
AU7857375A (en
Inventor
M Arin R Hurvitz E. Maron R. Levy R Sela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Priority to AU78573/75A priority Critical patent/AU498384B2/en
Publication of AU7857375A publication Critical patent/AU7857375A/en
Application granted granted Critical
Publication of AU498384B2 publication Critical patent/AU498384B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
AU78573/75A 1975-02-26 1975-02-26 Anti-timor composition Expired AU498384B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU78573/75A AU498384B2 (en) 1975-02-26 1975-02-26 Anti-timor composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU78573/75A AU498384B2 (en) 1975-02-26 1975-02-26 Anti-timor composition

Publications (2)

Publication Number Publication Date
AU7857375A AU7857375A (en) 1976-08-26
AU498384B2 true AU498384B2 (en) 1979-03-08

Family

ID=3758567

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78573/75A Expired AU498384B2 (en) 1975-02-26 1975-02-26 Anti-timor composition

Country Status (1)

Country Link
AU (1) AU498384B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0055115A1 (en) * 1980-12-22 1982-06-30 Teijin Limited Cytotoxic protein hybrid and process for the preparation thereof
EP0055575A1 (en) * 1980-12-22 1982-07-07 Teijin Limited Protein hybrid having cytotoxicity and process for the preparation thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448663A (en) * 1982-07-06 1984-05-15 The Dow Chemical Company Double L-shaped electrode for brine electrolysis cell

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0055115A1 (en) * 1980-12-22 1982-06-30 Teijin Limited Cytotoxic protein hybrid and process for the preparation thereof
EP0055575A1 (en) * 1980-12-22 1982-07-07 Teijin Limited Protein hybrid having cytotoxicity and process for the preparation thereof

Also Published As

Publication number Publication date
AU7857375A (en) 1976-08-26

Similar Documents

Publication Publication Date Title
AU497066B2 (en) Photocoplymerizable composition
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1025376A (en) Pourer-stopper
AU1230276A (en) Amidinoureas
AU1441776A (en) Thieno-pyridines
AU1373876A (en) Bottlecap
AU497446B2 (en) Composition
AU1128976A (en) Magneto-alternator
AU1637076A (en) Banjo-shaped axle-casing
AU1417076A (en) Propargyl-2 phenylamino-2-impazolines
AU1565576A (en) L- pyroglutamyl-l-prolinamide
AU511364B2 (en) Absorption-refrigerant composition
AU503344B2 (en) Substituted sufamylbenzylamines
AU1520376A (en) Benzocycloheptathiophens
AU1408076A (en) Lysolipin Antibioties
AU498623B2 (en) Matchhead compositions
AU1191776A (en) Fluoro-prostaglandins
AU505910B2 (en) Neamatocidal composition
AU1393076A (en) Dihydromocimycin
AU498384B2 (en) Anti-timor composition
AU1398876A (en) Aryl-di-thioureas
AU1612176A (en) Fluoro-steroids
AU1625476A (en) Aryltetralins
AU505567B2 (en) Substituted benzenedisulfonamide